0001437749-20-002040.txt : 20200207 0001437749-20-002040.hdr.sgml : 20200207 20200207161507 ACCESSION NUMBER: 0001437749-20-002040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200206 FILED AS OF DATE: 20200207 DATE AS OF CHANGE: 20200207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Latkin Jed CENTRAL INDEX KEY: 0001554593 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 20587601 MAIL ADDRESS: STREET 1: 152 W. 57TH STREET STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 4 1 rdgdoc.xml FORM 4 X0306 4 2020-02-06 0000810509 NAVIDEA BIOPHARMACEUTICALS, INC. NAVB 0001554593 Latkin Jed 4995 BRADENTON AVE., SUITE 240 DUBLIN OH 43017 1 1 CEO, COO & CFO Stock Option 1.06 2020-02-06 4 A 0 100000 0.001 A 2030-02-06 Common Stock 100000 203250 D Stock options will vest one-third on each of the first three anniversaries of the date of grant. /s/ Jed A. Latkin 2020-02-07